Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bettelheim

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Blut|July 1, 1988
Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromesK Geissler, W Hinterberger, U Jäger, et al.
Science (New York, N.Y.)|August 2, 1991
Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individualsR Valenta, M Duchêne, K Pettenburger, et al.
Wiener Klinische Wochenschrift|April 3, 1987
[Oral anticoagulant therapy--renaissance of an old therapy?]K Lechner, C Korninger, P Kyrle, et al.
Thrombosis and Haemostasis|August 30, 1983
T-cell alterations in hemophiliacs treated with commercial clotting factor concentratesK Lechner, H Niessner, P Bettelheim, et al.
Blood|February 15, 1991
Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemiaP Bettelheim, P Valent, M Andreeff, et al.
Blood|March 1, 1992
In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primatesK Geissler, P Valent, P Bettelheim, et al.
Annals of Hematology|October 1, 1994
High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL)--a single-institution studyR Scherrer, P Bettelheim, K Geissler, et al.
Annals of Hematology|July 1, 1991
Hepatic and splenic abscesses--a common complication of intensive chemotherapy of acute myeloid leukemia (AML). A prospective studyN Grois, G Mostbeck, R Scherrer, et al.
Experimental Hematology|August 1, 1993
Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4C Sillaber, D Bevec, J H Butterfield, et al.
Wiener Klinische Wochenschrift|August 5, 1988
[High dosage and intermediate dosage cytosine arabinoside in the treatment of secondary leukemias]T Leitha, U Jäger, I Schwarzinger, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Blut|July 1, 1988
Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromesK Geissler, W Hinterberger, U Jäger, et al.
Science (New York, N.Y.)|August 2, 1991
Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individualsR Valenta, M Duchêne, K Pettenburger, et al.
Wiener Klinische Wochenschrift|April 3, 1987
[Oral anticoagulant therapy--renaissance of an old therapy?]K Lechner, C Korninger, P Kyrle, et al.
Thrombosis and Haemostasis|August 30, 1983
T-cell alterations in hemophiliacs treated with commercial clotting factor concentratesK Lechner, H Niessner, P Bettelheim, et al.
Blood|February 15, 1991
Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemiaP Bettelheim, P Valent, M Andreeff, et al.
Blood|March 1, 1992
In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primatesK Geissler, P Valent, P Bettelheim, et al.
Annals of Hematology|October 1, 1994
High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL)--a single-institution studyR Scherrer, P Bettelheim, K Geissler, et al.
Annals of Hematology|July 1, 1991
Hepatic and splenic abscesses--a common complication of intensive chemotherapy of acute myeloid leukemia (AML). A prospective studyN Grois, G Mostbeck, R Scherrer, et al.
Experimental Hematology|August 1, 1993
Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4C Sillaber, D Bevec, J H Butterfield, et al.
Wiener Klinische Wochenschrift|August 5, 1988
[High dosage and intermediate dosage cytosine arabinoside in the treatment of secondary leukemias]T Leitha, U Jäger, I Schwarzinger, et al.
Pageof 14